India: U.S. Pharma Behind Ranbaxy Ban?
The Union health ministry has come to the defence of Ranbaxy, alleging that vested interests were behind the US ban on 30 drugs of the Indian pharma major. The US Food and Drug Administration (FDA) was being pressurised by political and pharma lobbies to act against Ranbaxy, a top official of the ministry said.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.